Drug Type Trispecific antibody |
Synonyms- |
Target |
Mechanism Ang2 inhibitors(Angiopoietin-2 inhibitors), VEGF-A inhibitors(Vascular endothelial growth factor A inhibitors), VEGF-C inhibitors(Vascular endothelial growth factor C inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Retinal Diseases | Preclinical | CN | 01 Dec 2023 |